Assessing the impact of infection prevention – an incremental cost-benefit analysis

Authors :: Jan-Willem Dik
Mariette Lokate
Ariane Kirste
Ron Hendrix
Lo-Ten-Foe, J. R.
Maarten Postma
Bhanu Sinha
Alex Friedrich
Microbes in Health and Disease (MHD)
Methods in Medicines evaluation & Outcomes research (M2O)
PharmacoTherapy, -Epidemiology and -Economics
Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE)
Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)
Value, Affordability and Sustainability (VALUE)
Source :: University of Groningen, 26th European Congress of Clinical Microbiology and Infectious Diseases

Subjects :: Cost-Benefit Analysis
ComputingMethodologies_DOCUMENTANDTEXTPROCESSING
NOSOCOMIAL OUTBREAKS
infection prevention
GeneralLiterature_REFERENCE(e.g.,dictionaries,encyclopedias,glossaries)

Database :: OpenAIRE
Journal :: University of Groningen, 26th European Congress of Clinical Microbiology and Infectious Diseases
Accession number :: edsair.dedup.wf.001..4f45b09afe169ad0c83635cdd89f8b79

Tools